Resource Guide
SYNGAP1 Resource Guide
Production and distribution of this resource are made possible by an educational grant from Greenwich Biosciences, acquired by Jazz Pharmaceuticals, a leader in the science, development, and commercialization of cannabinoid-based prescription medicines.
SYNGAP1 Natural History Study & Registry
Not Recruiting New Participants
Data Available to Researchers Studying SYNGAP1-Related Disorders
For SYNGAP1 Registry Data requests, please contact the National Organization for Rare Disorders (NORD), attention: Janine Lewis, at jlewis@rarediseases.org for more information regarding data from the 8-year-long prospective Natural History study.
SYNGAP1 Caregiver Resources
The SYNGAP1 Foundation, in partnership with CNF and Unite Us, aims to bridge gaps in support networks for SYNGAP1-related Disorders. Join us in building a stronger, more inclusive community, as we strive to provide invaluable resources and support for affected individuals and families nationwide.
Voice of SYNGAP1: EL-PFDD Meeting
Voice of the Patient & Caregiver Report: A Patient-Focused Drug Development Meeting for SYNGAP1-related Disorders